{
    "Case ID": "037870",
    "Crime_Name": [
        "Administrative Law Violation"
    ],
    "Crime_Type": [
        "Violations of Immigration Regulations"
    ],
    "Violation_Type": [],
    "Legal_Issue": [
        "Does the Minister have authority under the New Regulations to de-list the 053 Patent, and does the 053 Patent meet eligibility requirements?"
    ],
    "Governing_Law": [
        "New Regulations (SOR/2006-242), subsections 3(2) and 4(3)(c)",
        "Old Regulations (SOR/93-133)"
    ],
    "Application_Facts": [
        "The Minister argued that the 053 Patent did not meet eligibility requirements because it lacked specific claims for NSAID ulcers and included polymorphic forms. However, expert evidence showed the patent implicitly covered NSAID ulcers, and polymorphic claims do not disqualify it."
    ],
    "Decision_Outcome": [
        "The 053 Patent meets eligibility requirements and should not have been removed from the Patent Register."
    ],
    "Remedy_Requested": [
        "Judicial review application challenging the Minister's decision to de-list the patent"
    ],
    "Court_Ruling": [
        "Court allowed the application, ordering the reinstatement of the 053 Patent on the Patent Register."
    ],
    "Claimant_Status": [],
    "Defendant_Behavior": [
        "The Minister de-listed the 053 Patent based on interpretation of eligibility requirements under the New Regulations."
    ],
    "Grounds_for_Claim": [
        "Dispute over interpretation of New Regulations leading to de-listing of a patent."
    ],
    "Legal_Standard": [],
    "Assessment_Factor": [],
    "Applicable_Legislation": [
        "New Regulations (SOR/2006-242)",
        "Old Regulations (SOR/93-133)"
    ],
    "Procedural_Issue": [
        "Judicial review"
    ],
    "Review_Standard": [],
    "Credibility_Assessment": [
        "Expert evidence was considered credible in showing implicit coverage of NSAID ulcers."
    ],
    "Evidence_Used": [
        "Expert evidence regarding patent coverage and polymorphic forms"
    ],
    "Legal_Provision_Cited": [
        "Subsections 3(2) and 4(3)(c) of SOR/2006-242"
    ],
    "Application_Basis": [
        "Interpretation of regulatory provisions regarding patent eligibility"
    ],
    "Evidence_Assessed": [
        "Expert testimony on patent scope and technical claims"
    ],
    "Relief_Sought": [
        "Reinstatement of the 053 Patent on the Patent Register"
    ],
    "Governing_Rule": [
        "New Regulations (SOR/2006-242), subsections 3(2) and 4(3)(c)"
    ],
    "Evidentiary_Deficiency": [],
    "Outcome": [
        "Court allowed the application and ordered reinstatement."
    ],
    "Decisional_Body": [
        "Court"
    ],
    "Harm_Assessment": [],
    "Cause_Description": [
        "Dispute over interpretation of New Regulations leading to de-listing of a patent."
    ],
    "Evidence_Handling": [
        "Expert evidence was admitted and found persuasive."
    ],
    "Legal_Provision_Violated": [
        "None found; the Minister's interpretation was deemed incorrect."
    ],
    "Evidence_Issues": [],
    "Residency_Compliance": [],
    "Misrepresentation_Element": [],
    "Legal_Provision": [
        "SOR/2006-242, subsections 3(2) and 4(3)(c); SOR/93-133"
    ],
    "Jurisdictional_Issue": [],
    "Evidence_Assessment": [
        "Expert evidence assessed as sufficient to establish implicit coverage of NSAID ulcers and validity of polymorphic claims"
    ],
    "Decision_Rationale": [
        "The 053 Patent meets eligibility requirements under the correct interpretation of the regulations."
    ],
    "Country_of_Origin": [],
    "Decision_Making_Body": [
        "Minister"
    ],
    "Evidentiary_Issues": [],
    "Legal_Standard_Applied": []
}